Patients can monitor their individual tolerance and adjust their intake accordingly
This has become evident mostly in recent years with the advent of single-cell RNA sequencing techniques, which have helped to unravel the vast heterogeneity and plasticity of this cell type ( Another important conceptual shift in the field of fibroblast research is the recognition that these cells can be drivers of disease, rather than mere responders to the inflammatory or pathogenic microenvironment
doi:10.1002/mabi.202200019 Canapp SO, Farese JP, Schultz GS, et al
Indeed, the combination of D + Q is more effective and allows to target more senescent cell types (compared to the use of each drug alone), by inhibiting the pro-survival pathways induced in senescent cells, notably in idiopathic pulmonary fibrosis (IPF) 10,11,12 , diabetes and chronic kidney disease 13 or Alzheimers disease 14